Dr. Neil E. Faulkner
Claim this profileUniversity of Tennessee - Knoxville
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
6 reported clinical trials
12 drugs studied
Area of expertise
1Lung Cancer
Stage IV
Stage III
Stage II
2Non-Small Cell Lung Cancer
Stage IV
Stage III
PD-L1 positive
Affiliated Hospitals
Clinical Trials Neil E. Faulkner is currently running
Fianlimab + Cemiplimab
for Non-Small Cell Lung Cancer
This trial is testing a new drug combination for patients with advanced lung cancer. It aims to see if using two drugs together is more effective than one alone. The study also looks at side effects, how the drugs are processed in the body, and their impact on quality of life.
Recruiting0 awards Phase 2 & 3
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
More about Neil E. Faulkner
Clinical Trial Related2 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Neil E. Faulkner has experience with
- Cemiplimab
- Fianlimab
- Paclitaxel
- Pemetrexed
- Carboplatin
- Pembrolizumab
Breakdown of trials Neil E. Faulkner has run
Lung Cancer
Non-Small Cell Lung Cancer
Squamous Cell Carcinoma
Anaplastic Large Cell Lymphoma
ALK Gene Rearrangement
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Neil E. Faulkner specialize in?
Neil E. Faulkner focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Neil E. Faulkner currently recruiting for clinical trials?
Yes, Neil E. Faulkner is currently recruiting for 4 clinical trials in Knoxville Tennessee. If you're interested in participating, you should apply.
Are there any treatments that Neil E. Faulkner has studied deeply?
Yes, Neil E. Faulkner has studied treatments such as Cemiplimab, Fianlimab, Paclitaxel.
What is the best way to schedule an appointment with Neil E. Faulkner?
Apply for one of the trials that Neil E. Faulkner is conducting.
What is the office address of Neil E. Faulkner?
The office of Neil E. Faulkner is located at: University of Tennessee - Knoxville, Knoxville, Tennessee 37920 United States. This is the address for their practice at the University of Tennessee - Knoxville.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.